NLS Pharmaceutics Correlations

NLSP Stock  USD 1.51  0.01  0.67%   
The current 90-days correlation between NLS Pharmaceutics and Indaptus Therapeutics is -0.02 (i.e., Good diversification). The correlation of NLS Pharmaceutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

NLS Pharmaceutics Correlation With Market

Significant diversification

The correlation between NLS Pharmaceutics AG and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding NLS Pharmaceutics AG and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NLS Pharmaceutics AG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Moving against NLS Stock

  0.4PG Procter GamblePairCorr
  0.33WM Waste ManagementPairCorr
  0.31LUCD Lucid DiagnosticsPairCorr
  0.55JNJ Johnson JohnsonPairCorr
  0.46XOM Exxon Mobil Corp Aggressive PushPairCorr
  0.45T ATT Inc Earnings Call TodayPairCorr
  0.41CVX Chevron Corp Sell-off TrendPairCorr
  0.32MMM 3M CompanyPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
PTIXKTTA
PTIXNRBO
PTIXQNRX
KTTANRBO
QNRXKTTA
LIXTKTTA
  
High negative correlations   
ACRVANEB
MIROPTIX
MIROACRV
MIRONGENF
MIROANEB
MIROLIXT

Risk-Adjusted Indicators

There is a big difference between NLS Stock performing well and NLS Pharmaceutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze NLS Pharmaceutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
NRBO  3.99 (0.40) 0.00 (0.43) 0.00 
 8.05 
 25.83 
INDP  3.27 (0.43) 0.00  40.53  0.00 
 6.32 
 20.25 
KTTA  5.03 (0.76) 0.00 (0.44) 0.00 
 8.14 
 53.63 
QNRX  5.40 (0.91) 0.00  1.83  0.00 
 14.29 
 57.78 
LIXT  4.91 (0.48) 0.00  0.43  0.00 
 11.55 
 33.08 
ANEB  5.72  0.62  0.10  0.37  5.70 
 19.58 
 40.87 
NGENF  2.17  0.10  0.04  0.03  2.46 
 4.95 
 32.23 
ACRV  4.13 (0.16) 0.00 (0.16) 0.00 
 10.17 
 30.57 
PTIX  6.79 (0.59) 0.00  0.33  0.00 
 13.33 
 45.66 
MIRO  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

NLS Pharmaceutics Corporate Management

Sharon KeysHead AffairsProfile
Nicole CPAChief OfficerProfile
iur LLMG CounselProfile
Chad MBAChief OfficerProfile
Elena ThyenPighinChief OfficerProfile